Arthritis and Rheumatic Disease Specialties

Aventura, Florida 33180

0 studies enrolling now · 24 studies all time

What they study most

Active Systemic Lupus Erythematosus, Ankylosing Spondylitis, Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, Immunocompromised, Lupus Erythematosus, Systemic, Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Psoriatic Arthritis, Rhematoid Arthritis

Studies at this site

• A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults — Stopped early
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis — Stopped early
• Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. — Completed
• Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus — Stopped early
• ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis — Stopped early
• A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip — Completed
• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip — Stopped early
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed
• A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus — Completed
• Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus — Completed
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). — Completed
• Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis — Completed
• An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate — Completed
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). — Completed
• The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients — Completed
• A Study of Belimumab in Subjects With Systemic Lupus Erythematosus — Completed
• Methotrexate-Inadequate Response Study — Completed
• Abatacept Versus Adalimumab Head-to-Head — Completed
• A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) — Completed
• A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01 — Stopped early
• Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) — Completed
• Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) — Completed
• A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis — Completed